Is Ares Capital Corp a Buy After Its Latest Earnings Report?

Ares Capital reported Q3 core earnings of $0.46 per share, down from $0.50 a year earlier and below its $0.48 quarterly dividend, tightening current dividend coverage; $1.37 per share of carried-forward taxable income provides a cushion. The company agreed to acquire MidCap Financial Investment Corporation in a $2.6 billion transaction, which it expects to be modestly accretive to core EPS and supportive of future dividends. ARCC’s 2.4% non-accrual rate was unchanged sequentially and below its historical and peer averages, but NAV declined to $19.31 from $19.94 over the past year; shares were cited at $18.75, a roughly 3% discount to NAV and a 10.2% annualized dividend yield.

Analysis

The key risk is not one quarter of weak coverage; it is whether lower base rates and/or credit costs make the earnings shortfall persistent. For a floating-rate BDC, rate cuts can compress asset yields faster than funding costs reset, while stressed borrowers can push non-accruals and realized losses higher. Taxable-income spillover can bridge distributions temporarily, but it is not evidence that recurring earnings cover the payout.

The MFIC transaction could add scale and earnings, but “modestly accretive” is a company estimate, not yet a demonstrated offset to portfolio yield compression or integration costs. The key diligence points are financing and exchange terms, portfolio marks at close, and post-close core EPS and NAV—not headline portfolio size. A broader BDC read-through is also possible: if ARCC’s reported credit metrics weaken, investors may demand a wider discount to NAV across the sector.

Near term, income demand may support ARCC, but the roughly NAV-level valuation leaves limited cushion if NAV continues to erode. Over 1–3 months, closing terms and rate expectations matter; over 6–18 months, realized credit performance and recurring dividend coverage determine whether the high yield is compensation or a warning. The contrarian risk to the bearish read is that diversified underwriting and spillover income could absorb a temporary earnings dip without a cut.

Key Decisions for Investors

• Avoid chasing the yield; for new exposure, wait for either a wider discount to NAV or evidence that recurring core earnings cover the dividend. The current near-NAV valuation offers little protection against another NAV decline.
• For existing ARCC holders, retain only a monitored income position rather than treating spillover taxable income as permanent coverage. Reassess if core earnings remain below distributions for two consecutive quarters, NAV continues to fall, or non-accruals rise above the company’s historical range.
• Treat MFIC accretion as a catalyst to verify, not a reason to buy ahead of closing. Track transaction financing, acquired-portfolio marks, and the first post-close reports for core EPS, NAV, and credit quality; adverse marks or delayed accretion would weaken the thesis.
• Falsification on the positive side: sustained dividend coverage from recurring earnings alongside stable NAV and non-accruals would support adding exposure. On the negative side, a dividend reduction, material deterioration in credit metrics, or a guidance cut would invalidate the income-support case.